DEMYELINATING DISEASE: Is TOPIC the last trial for clinically isolated syndrome?

    loading  Checking for direct PDF access through Ovid

Abstract

The recent TOPIC trial found that teriflunomide could prevent relapses in patients with clinically isolated syndrome (CIS). Many other multiple sclerosis (MS) therapies are effective for CIS, because CIS is the first clinical manifestation of MS for most patients. Questions remain over the utility of future trials like TOPIC.

Related Topics

    loading  Loading Related Articles